A clinical study on the effect of Panchatikta Pancha Prashritik Basti in the management of Madhumeha w.s.r to type 2 DM

---

Original Article

Author Details : Rajeev Kumar Pandey*, Santosh Kumar Bhatted

Volume : 6, Issue : 2, Year : 2020

Article Page : 82-87

https://doi.org/10.18231/j.jpmhh.2020.016

Suggest article by email

Get Permission

---

Abstract

Madhumeha (Type 2 Diabetes mellitus) is a syndrome with disturbed metabolism and hereditary immune mediated involvement and its becomes worse with evident of life threatening complications like Neuropathy, Nephropathy, Retinopathy along with pathological changes that involves small and large vessels leading to myocardial problems and cerebrovascular accidents.
Ayurveda emphasizes on the radical treatment by the use of Panchakarma therapies, which are primarily bio-cleansing in nature and corrects the basic pathological factors involved in the disease and regularize metabolism. The drug used in Panchakarma detoxification process are nontoxic, medicated oils and ghee, together with Panchakarma procedure sequentially loosen and remove lipid soluble toxicants from their deposited sites and stimulate their elimination. In Ayurveda Panchatikta pancha prashritika Basti (PPP Basti) is specially indicated for Madhumeha.1 In this clinical study PPP Basti has given in diagnosed Diabetic Patient and their result shown statistically significant improvement in the sign and symptoms.

Keywords: Madhumeha (Diabetes Mellitus), PPP Basti (Panchatikta pancha prashritika Basti- A medicated.
Ayurvedic enema).

How to cite : Pandey R K , Bhatted S K , A clinical study on the effect of Panchatikta Pancha Prashritik Basti in the management of Madhumeha w.s.r to type 2 DM. J Prev Med Holist Health 2020;6(2):82-87

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.